GC Biopharma Corp.
006280.KS
Updated: 24/09/2026, 05:05:59
GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.
No summaries found.
- Share price
- ₩123,300
- Market cap
- ₩1.41T
- Exchange
- KSC
- Currency
- KRW
- CEO
- Huh Eun-chul
- Employees
- 2,351
- IPO date
- 04/01/2000
- Beta
- 0.728
- Last dividend
- ₩0
- Day range
- ₩123,100 – ₩125,400
- 52-week range
- ₩105,900 – ₩183,800
- 1-day performance
- 0.00%
- 1-year performance
- 16.43%
- Current drawdown (1Y)
- -32.92%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- KR7006280002
- Created
- 07/09/2026, 05:15:59
- Last update
- 24/09/2026, 05:05:59
Track GC Biopharma Corp. with an AI analyst
See which prediction-market events move 006280.KS, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.